Novozymes obtains United States patent.
Novozymes A/S (Bagsvaerd, Denmark) has patented lipolytic enzymes
which are chemically modified by covalently linking one or more
(particularly 1-3) hydrophobic groups to the enzyme molecule. . . .
ChemoCentryx obtains United States patent.
ChemoCentryx, Inc. (Mountain View, CA) has patented a modified cell
migration assay allowing for improved identification and discrimination
of chemokine receptor antagonists from non-specific . . .
Applied Research Systems obtains United States patent.
Applied Research Systems ARS Holding N.V. (Curacao, Netherlands)
has patented a method for improving homogeneity and/or secretion of a
recombinant protein of interest expressed in mammalian cells . . .
Amgen obtains United States patent.
Amgen, Inc. (Thousand Oaks, CA) has patented DNA sequences coding
for a TNF-binding protein and for the TNF receptor of which this protein
constitutes the soluble domain. The DNA sequences can be . . .
GliaMed obtains United States patent.
GliaMed, Inc. (New York, NY) has patented neurotrophic
N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type
immunophilins, their preparation and use as inhibitors of the . . .
ECI Biotech obtains United States patent.
ECI Biotech, Inc. (Worcester, WA) has patented a method for
expressing proteins as a fusion chimera with a domain of p26 or alpha
crystallin type proteins to improve the protein stability and . . .
Emmaus obtains United States patent.
Emmaus Foundation, Inc. (Fayetteville, AK) has patented a stable
continuous method for producing ethanol from the anaerobic bacterial
fermentation of a gaseous substrate containing at least one . . .
Gendaq obtains United States patent.
Gendaq Limited (London, Great Britain) and The Rockefeller
University (New York, NY) has patented a method of regulating
transcription in a plant cell from a DNA sequence comprising a target
DNA . . .
Massachusetts Institute of Technology obtains United States
patent.
Massachusetts Institute of Technology (Cambridge, MA) and Brigham
& Women's Hospital Inc. (Boston, MA) has patented methods and
products for suppressing a class II MI-IC-restricted immune response . . .
University of Arizona obtains United States patent.
University of Arizona (Tucson, AZ) has patented methods and
compositions for transgene expression in target cells. Expression
constructs using an inducible amplification system to drive . . .
University of Maryland obtains United States patent.
University of Maryland, Baltimore (Baltimore, MD) has patented a
composition comprising a novel Ca.sup.2+-activated,
[ATP].sub.i-sensitive nonspecific cation (NC.sub.Ca-ATP) channel is
described. . . .
Katholieke Universiteit Nijmegen obtains United States
patent.
Katholieke Universiteit Nijmegen (Nijmegen, Netherlands) has
patented use of a compound that binds to a C-type lectin on the surface
of a dendritic cell, in the preparation of a composition for . . .
Korea Kumho obtains United States patent.
Korea Kumho Petrochemical Co., Ltd. (Seoul, Korea) has patented
modified phytochrome A (PHYA) nucleic acid molecules in which Pr
absorption spectra have been shifted to longer wavelength . . .
Bayer obtains United States patent.
Bayer Aktiengesellschaft (Leverkusen, Germany) has patented nucleic
acid coding for enzyme activities of spinosyn biosynthesis and to the
relevant enzymes per se. Furthermore, the invention relates . . .
Cepheid enters agreement to exclusively license HPV portfolio
developed by Quantovir AB.
Cepheid (Sunnyvale, CA) has entered into an agreement to
exclusively license the Human Papillomavirus (HPV) patent portfolio held
by Quantovir AB of Sweden for the quantitative measurement of . . .
BioNanomatrix announces issuance of nanofluidics patent enabling
single molecule whole genome analysis.
BioNanomatrix, Inc. (Philadelphia, PA), a company developing
breakthrough nanoscale whole genome imaging and analytic platforms for
clinical genetics, cancer diagnostics and biomedical research, . . .
Bristol-Myers Squibb to acquire Adnexus.
Bristol-Myers Squibb Company (Princeton, NJ) and Adnexus
Therapeutics announced the companies have signed a definitive agreement
under which Bristol-Myers Squibb will acquire privately held . . .
MedImmune licenses reverse genetics technology to
GlaxoSmithKline.
MedImmune, Inc. (Gaithersburg, MD) licensed its proprietary reverse
genetics intellectual property to GlaxoSmithKline to support the
development and construction of new vaccine strains to produce . . .
United States awards $15 million grant to GeoVax' HIV/AIDS
vaccine program.
GeoVax Labs, Inc. (Atlanta, GA) announced receipt of an estimated
$15,000,000 Integrated Preclinical/Clinical AIDS Vaccine Development
(IPCAVD) Grant to support its HIV/AIDS vaccine program.
This . . .
ChemoCentryx demonstrates recently discovered chemokine receptor
essential in tumor growth.
ChemoCentryx, Inc. (Mountain View, CA), a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing therapeutics that target the chemokine system, . . .
|
|